"Designing Growth Strategies is in our DNA"

Clinical Trials Market Size, Share & Industry Analysis, By Phase (Phase I, Phase II, Phase III, and Phase IV), By Application (Oncology, CNS Disorder, Cardiology, Infectious Disease, Metabolic Disorder, Renal/Nephrology, and Others), and Regional Forecast, 2026-2034

Last Updated: December 15, 2025 | Format: PDF | Report ID: FBI106930

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Clinical Trials – by Key Countries, 2025
    2. R&D expenditures, by Key Players
    3. New Clinical Trials Initiatives, by Key Countries
    4. Key Industry Developments (Mergers, Partnerships, Acquisitions, etc.)
    5. Impact of COVID-19 on the Market
  5. Global Clinical Trials Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Clinical Trials Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Clinical Trials Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Clinical Trials Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Clinical Trials Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. IQVIA Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Laboratory Corporation of America Holdings
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Thermo Fisher Scientific Inc. 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Parexel International Corporation 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Medpace Holdings, Inc. 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Icon plc
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Syneos Health 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. WuXi AppTec
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Charles River Laboratories 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Pfizer Inc. 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. Lilly 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Clinical Trials – by Key Countries, 2025
    2. R&D expenditures, by Key Players
    3. New Clinical Trials Initiatives, by Key Countries
    4. Key Industry Developments (Mergers, Partnerships, Acquisitions, etc.)
    5. Impact of COVID-19 on the Market
  5. Global Clinical Trials Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Clinical Trials Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Clinical Trials Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Clinical Trials Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Clinical Trials Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Disease
      5. Metabolic Disorder
      6. Renal/Nephrology
      7. Others
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. IQVIA Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Laboratory Corporation of America Holdings
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Thermo Fisher Scientific Inc. 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Parexel International Corporation 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Medpace Holdings, Inc. 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Icon plc
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Syneos Health 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. WuXi AppTec
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Charles River Laboratories 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Pfizer Inc. 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. Lilly 
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Clinical Trials Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Clinical Trials Market Value Share (%), by Phase, 2025 & 2034

Figure 3: Global Clinical Trials Market Value Share (%), by Application, 2025 & 2034

Figure 4: Global Clinical Trials Market Value (USD billion), by Region, 2025 & 2034

Figure 5: North America Clinical Trials Market Value (USD billion), by Phase, 2025 & 2034

Figure 6: North America Clinical Trials Market Value Share (%), by Phase, 2025

Figure 7: North America Clinical Trials Market Value (USD billion), by Application, 2025 & 2034

Figure 8: North America Clinical Trials Market Value Share (%), by Application, 2025

Figure 9: North America Clinical Trials Market Value (USD billion), By Country, 2025 & 2034

Figure 10: North America Clinical Trials Market Value Share (%), By Country, 2025

Figure 11: Europe Clinical Trials Market Value (USD billion), by Phase, 2025 & 2034

Figure 12: Europe Clinical Trials Market Value Share (%), by Phase, 2025

Figure 13: Europe Clinical Trials Market Value (USD billion), by Application, 2025 & 2034

Figure 14: Europe Clinical Trials Market Value Share (%), by Application, 2025

Figure 15: Europe Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 16: Europe Clinical Trials Market Value Share (%), By Country/ Sub-region, 2025

Figure 17: Asia Pacific Clinical Trials Market Value (USD billion), by Phase, 2025 & 2034

Figure 18: Asia Pacific Clinical Trials Market Value Share (%), by Phase, 2025

Figure 19: Asia Pacific Clinical Trials Market Value (USD billion), by Application, 2025 & 2034

Figure 20: Asia Pacific Clinical Trials Market Value Share (%), by Application, 2025

Figure 21: Asia Pacific Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 22: Asia Pacific Clinical Trials Market Value Share (%), By Country/ Sub-region, 2025

Figure 23: Rest of the World Clinical Trials Market Value (USD billion), by Phase, 2025 & 2034

Figure 24: Rest of the World Clinical Trials Market Value Share (%), by Phase, 2025

Figure 25: Rest of the World Clinical Trials Market Value (USD billion), by Application, 2025 & 2034

Figure 26: Rest of the World Clinical Trials Market Value Share (%), by Application, 2025

Figure 27: Global Clinical Trials Market Share (%), By Company, 2025

Table 1: Global Clinical Trials Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 2: Global Clinical Trials Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 3: Global Clinical Trials Market Revenue (USD billion) Forecast, by Region, 2021–2034

Table 4: North America Clinical Trials Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 5: North America Clinical Trials Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 6: North America Clinical Trials Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 7: Europe Clinical Trials Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 8: Europe Clinical Trials Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 9: Europe Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 10: Asia Pacific Clinical Trials Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 11: Asia Pacific Clinical Trials Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 12: Asia Pacific Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 13: Rest of the World Clinical Trials Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 14: Rest of the World Clinical Trials Market Revenue (USD billion) Forecast, by Application, 2021–2034

Clinical Trials Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 151
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports